HomeABT • NYSE
add
Abbott Laboratories
Previous close
$106.89
Day range
$106.65 - $107.46
Year range
$89.67 - $121.64
Market cap
185.21B USD
Avg Volume
6.80M
P/E ratio
33.15
Dividend yield
2.06%
Primary exchange
NYSE
Top news
Q1 earnings report for Abbott Laboratories
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 9.96B | 2.23% |
Operating expense | 4.14B | 10.33% |
Net income | 1.22B | -7.06% |
Net profit margin | 12.29 | -9.10% |
Earnings per share | 0.98 | -4.85% |
EBITDA | 2.21B | -10.96% |
Effective tax rate | 14.69% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.28B | -23.64% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 38.83B | — |
Shares outstanding | 1.74B | — |
Price to book | 4.80 | — |
Return on assets | — | — |
Return on capital | 6.40% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 1.22B | -7.06% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. Wikipedia
Founded
1888
Headquarters
Website
Employees
114,000
